MSC with HIF-1α hyperexpression promoted reduction of brain infarct volume, improved neurobehavioral outcome and, additionally, inhibition of proinflammatory cytokine secretion while promotion of neurotrophin release. This evidence concerns the gene HIF1A and brain infarction.